BersonA, FauD. Fornacciari mechanisms for experimental buprenorphine hepatoxicity: Major role of mitochondrial dysfunction versus metabolic activation. J Hepatol, 34:261–269. 2001.
2.
HerveS, RiachiG, NobletC. Acute hepatitis due to buprenorphine administration. Eur J Gastroenterol Hepatol, 16:1033–1037. 2004.
3.
ZuinM, GiorginiA, SelmiC, BattezzatiPM, CocchiCA, CrosignaniA, BenettiA, InvernizziP, PoddaM. Acute liver and renal failure during treatment with buprenorphine at therapeutic dose. Dig Liver Dis, 41:e8–e10. 2009.
